Filter
722
Text search:
quality
assured
medical
products
Featured
Recommendations
86
New Publications
238
Language
Document type
No document type
384
Guidelines
120
Studies & Reports
112
Manuals
48
Strategic & Response Plan
43
Training Material
10
Situation Updates
2
Fact sheets
2
Resource Platforms
1
Countries / Regions
India
38
Global
30
Kenya
23
Nigeria
19
Western and Central Europe
19
Uganda
17
Ethiopia
13
Zambia
13
Ghana
12
Tanzania
11
Myanmar / Burma
11
Nepal
10
Liberia
9
Philippines
9
South–East Asia Region
9
Bangladesh
8
Eastern Europe
8
Malawi
7
Lesotho
7
Africa
7
Sierra Leone
6
Cambodia
6
South Africa
6
Latin America and the Carribbean
6
Ukraine
5
West and Central Africa
5
Asia
5
Burkina Faso
4
Zimbabwe
4
Rwanda
4
Namibia
4
East and Southern Africa
4
Senegal
3
Congo, Democratic Republic of
3
Pakistan
3
Middle East and North Africa
3
Guinea
2
South Sudan
2
Iraq
2
Afghanistan
2
Germany
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Sri Lanka
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Laos
2
Georgia
2
USA
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Jordan
1
Syria
1
Thailand
1
Benin
1
Central African Republic
1
Brazil
1
Switzerland
1
Botswana
1
Libya
1
Guatemala
1
Bhutan
1
Tajikistan
1
Estonia
1
Iran
1
North America
1
Gabon
1
Maldives
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
93
Public Health
47
Pharmacy & Technologies
35
Women & Child Health
29
Key Resources
21
Capacity Building
11
Toolboxes
TB
87
AMR
78
HIV
64
Pharmacy
51
COVID-19
36
NTDs
25
Rapid Response
21
Mental Health
17
Caregiver
12
Ebola
10
Polio
10
Conflict
10
Refugee
10
Global Health Education
10
Disability
9
NCDs
9
Natural Hazards
6
Planetary Health
6
Zika
5
Health Financing Toolbox
3
Specific Hazards
2
Cholera
1
Social Ethics
1
Afr J Tradit Complement Altern Med. (2013) 10(5):210-229
Plants are important sources of medicines. Herbal medicines in Lesotho are exposed to excessive exploitation and habitat destruction. Comprehensive information to promote proper use and conservation of these herbal medicines is lacking. ...
Plants are important sources of medicines. Herbal medicines in Lesotho are exposed to excessive exploitation and habitat destruction. Comprehensive information to promote proper use and conservation of these herbal medicines is lacking. ...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Prices people pay for medicines.
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
This survey is part of a series of eight country surveys conducted in the context of the People that Deliver Initiative (peoplethatdeliver.org). This global initiative, which brings together the world’s largest organizations, aims to improve health services performance through the professionalizat
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current
...
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist
...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was
...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
